1. Home
  2. QTTB vs SNYR Comparison

QTTB vs SNYR Comparison

Compare QTTB & SNYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • SNYR
  • Stock Information
  • Founded
  • QTTB 2015
  • SNYR 2010
  • Country
  • QTTB United States
  • SNYR United States
  • Employees
  • QTTB N/A
  • SNYR N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • SNYR
  • Sector
  • QTTB Health Care
  • SNYR
  • Exchange
  • QTTB Nasdaq
  • SNYR NYSE
  • Market Cap
  • QTTB 19.0M
  • SNYR 16.6M
  • IPO Year
  • QTTB N/A
  • SNYR N/A
  • Fundamental
  • Price
  • QTTB $1.92
  • SNYR $2.07
  • Analyst Decision
  • QTTB Hold
  • SNYR Strong Buy
  • Analyst Count
  • QTTB 8
  • SNYR 1
  • Target Price
  • QTTB $24.00
  • SNYR $10.00
  • AVG Volume (30 Days)
  • QTTB 90.3K
  • SNYR 50.5K
  • Earning Date
  • QTTB 05-08-2025
  • SNYR 05-15-2025
  • Dividend Yield
  • QTTB N/A
  • SNYR N/A
  • EPS Growth
  • QTTB N/A
  • SNYR N/A
  • EPS
  • QTTB N/A
  • SNYR 0.30
  • Revenue
  • QTTB N/A
  • SNYR $33,592,914.00
  • Revenue This Year
  • QTTB N/A
  • SNYR N/A
  • Revenue Next Year
  • QTTB N/A
  • SNYR $15.97
  • P/E Ratio
  • QTTB N/A
  • SNYR $6.33
  • Revenue Growth
  • QTTB N/A
  • SNYR N/A
  • 52 Week Low
  • QTTB $1.38
  • SNYR $0.12
  • 52 Week High
  • QTTB $53.79
  • SNYR $10.00
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 57.55
  • SNYR N/A
  • Support Level
  • QTTB $1.56
  • SNYR N/A
  • Resistance Level
  • QTTB $1.96
  • SNYR N/A
  • Average True Range (ATR)
  • QTTB 0.15
  • SNYR 0.00
  • MACD
  • QTTB 0.03
  • SNYR 0.00
  • Stochastic Oscillator
  • QTTB 87.80
  • SNYR 0.00

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About SNYR SYNERGY CHC CORP

Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.

Share on Social Networks: